Elmer Schabel, MD, is working since the year 1997 as a clinical assessor at the BfArM, the drug regulatory authority in Germany, where he is responsible for all pre- and post-licensing regulatory activity regarding chemically defined medicinal products in the field of Gastroenterology and Hepatology.
Later, he subsequently became involved in the European regulatory network within the European Medicines Agency (EMA). In 2007 he was appointed Member of the Scientific Advice Working Party (SAWP) at EMA, the group which is responsible for giving Scientific Advice and Protocol Assistance to companies developing new substances, and for advice and qualification with regard to development of novel methodologies, including biomarkers. In 2011 he was appointed Chair of the Gastroenterology Drafting Group, the groups responsible for the development of scientific guidelines in the field of Gastroenterology and Hepatology. He has served on numerous occasions as partner for the dialogue between the stakeholders, including industry, academia, and patients and became involved into the activities of the Liver Forum as a Member of the Steering Committee.
Dr. Schabel has obtained his MD qualification at the Free University of Berlin.